Capital expenditure increased 76.2%
Capital expenditure changed +76.2% from the comparable as-filed period.
$28.1M→$49.5M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →AEIS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Stock-based compensation increased 57.4%
Stock-based compensation changed +57.4% from the comparable as-filed period.
$13.6M→$21.4M2 prior comparisons
Capex / revenue moved 226 bp higher
Capex / revenue changed +226 basis points from the comparable as-filed period.
6.36%→8.62%2 prior comparisons
Inventory / revenue moved 360 bp higher
Inventory / revenue changed +360 basis points from the comparable as-filed period.
90.12%→93.73%2 prior comparisons
Cost of revenue increased 21.5%
Cost of revenue changed +21.5% from the comparable as-filed period.
$278.1M→$338.0M2 prior comparisons
Operating cash-flow margin moved 457 bp higher
Operating cash-flow margin changed +457 basis points from the comparable as-filed period.
10.24%→14.81%2 prior comparisons
Research & development increased 10.2%
Research & development changed +10.2% from the comparable as-filed period.
$59.0M→$65.0M2 prior comparisons
Free-cash-flow margin moved 231 bp higher
Free-cash-flow margin changed +231 basis points from the comparable as-filed period.
3.87%→6.18%2 prior comparisons
Selling, general & administrative increased 15.3%
Selling, general & administrative changed +15.3% from the comparable as-filed period.
$60.2M→$69.4M2 prior comparisons
R&D / revenue moved 204 bp lower
R&D / revenue changed -204 basis points from the comparable as-filed period.
13.36%→11.32%2 prior comparisons
Receivables / revenue moved 145 bp higher
Receivables / revenue changed +145 basis points from the comparable as-filed period.
68.86%→70.30%2 prior comparisons
SBC / revenue moved 65 bp higher
SBC / revenue changed +65 basis points from the comparable as-filed period.
3.08%→3.73%2 prior comparisons
Current ratio decreased 7.3%
Current ratio changed -7.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
4.09→3.794 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.